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The percentage of cancer-related deaths attributable to diet and tobacco globally is reported to be as high 
as 60–70%. A large number of dietary compounds have gained research interest and tested to determine 
their chemopreventive / antiproliferative effects on in-vivo/in-vitro models. The present study effect of 
flavonoid fisetin on proliferation of human lung carcinoma cells A549 and NCI-H460 was investigated. 
The effect of fisetin on cell growth was investigated by MTT, Crystal violet, XTT, LDH release, and 
colony forming assays. Cell proliferation was assessed by BrdU incorporation test. Further, cell 
morphology and cytopathology was analyzed by crystal violet test and hematoxylin and eosin staining. 
Results of study revealed that fisetin treatment exerted a dose dependent decrease in the growth of A549 
and NCI-H460 cells with IC50 values of 190µM and 210µM respectively. It also inhibited cell 
proliferation and colony formation in both A549 and NCI-H460 cells. Cytopathology studies exhibited 
features such as nuclear fragmentation, cytoplasmic vacuolation, karyorrhexis, chromatin condensation, 
which were suggestive of apoptotic cell death. Results of the study indicate growth inhibitory, anti-
proliferative and pro-apoptotic effects of fisetin on lung carcinoma cells. 
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Chemoprevention and functional foods are new areas of great 
interest in the prevention of diseases. Further, it has been 
reported that dietary and environmental factors account about 
30% of cancers, suggesting that diet plays an important role in 
the prevention of cancer (Doll & Peto, 1981). In the past two 
decades a large number of dietary compounds have been tested 
to determine their chemopreventive / anti proliferative activity 
in vivo/in vitro model systems. Flavonoids are naturally 
occurring polyphenolic compounds that have very low 
molecular weight and form a large group of secondary plant 
metabolites. These compounds have various interesting 
biological activities such as antioxidative, antimicrobial, 
anticarcinogenic and cardioprotective (Khan et al., 2008; Moon 
et al., 2006). Fisetin a major flavonoid has been reported to 
possess pharmacological properties like anticancer (Huntington 
et al., 2004), angiogenesis-inhibition (Hirata et al., 2003), anti-
inflammatory (Kemik et al., 2011), pro-apoptotic (Liu et al., 
2012) and anti-invasive effects (Behrens et al., 2001). Thus 
fisetin could confer a valuable advantage in treatment of 
various types of cancers. Like many other flavonoids, fisetin 
(3, 3, 4, 7-tetrahydroxy flavone), is widely distributed among 
fruits and vegetables and is found in plants at a concentration 
of 160 µg/g (Arai et al., 2000).  
 
Lung cancer is the second most common cancer and is the 
major cause of cancer related death in both men and women. 
Instead of great advancements in chemotherapy survival rates 
for lung cancer patients is still disappointing. Majority of the 
lung cancer patients are in stages III and IV when diagnosed 
making curative surgery difficult. Based on cell morphology 
pulmonary cancer is primarily categorized into Non Small Cell 
Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma 
(SCLC). NSCLC is further classified into adenocarcinoma, 
squamous cell lung carcinoma, and large cell lung carcinoma 
and comprises nearly 75 to 80% of all lung cancers.The mean 
5- year survival rate for those with NSCLC is approximately 
15% (Carbone & Felip, 2011). Recent evidences strongly 
suggest abnormalities in JAK/STAT signaling pathway is 
involved in the oncogenesis of several cancers especially lung 
cancers (Song et al., 2011). STAT3 is persistently activated in 
about 50% of NSCLC primary tumors and lung cancer–derived 
cell lines (Mukohara et al.,2003; Seki et al.,2004; Haura et al., 
2005). Constitutive activation of the P13K/Akt pathway has 
also been reported in 90% of NSCLC cell lines, thus 
promoting cell survival and resistance to chemotherapy or γ-
radiation (West et al., 2003). 
 
Exploiting and exploring actions of natural products on 
suitable model systems  has led to development of several life 
saving drugs available in the market today to treat dreadful 
diseases. Hence, this study is an attempt to understand the 
anticancer properties of dietary flavonoid/small molecule 
inhibitor fisetin on suitable human NSCLC in vitro model 
systems.  




Fisetin (3,3′,4′,7-tetrahydroxyflavone) was procured from 
(sigma , St. Louis , MO, USA). A stock solution of 2.86mg/ ml 




2.2 In-vitro model systems 
 
2.2.1 Isolation and culture of lymphocytes 
 
Fresh blood was collected and lymphocytes were separated by 
following the previously described protocol (Boyum, 1968). 
Based on the density gradient centrifugation the lymphocyte 
separation carried out using separation media (Hisep 
TM-
LSM 
1001) procured from Himedia, India. Lymphocytes were 
culture in complete DMEM media containing 10% FBS at 
37
0
C with 5% CO2 and 95% humidity in a CO2 incubator. 
 
2.2.2 Procurement and maintenance of cell lines 
 
The NSCLC pulmonary carcinoma cell lines A-549 
(adenocarcinoma), NCI-H460 (large cell lung carcinoma) and 
normal lung fibroblast cells WI-26 were procured from 
National Centre for Cell Science (NCCS), Pune, India. The – 
A-549, NCI-H460 and WI-26 cells were cultured in Hams 
F12K medium (AL106A- Himedia, India), RPMI 1640 
(AL171A- HiMedia, India) and DMEM (AL007- Himedia 
India) respectively. The media were supplemented with 10% 
Fetal Bovine Serum (FBS, RM112, Himedia, India), 1X and 
Antibiotic and Antimycotic solution (A007, Himdia, India) for 
growth of cells, and cells were grown under standard growth 
conditions (95% humidity, 5% CO2 and temperature 37◦C) in 
a CO2 incubator. 
 
2.3 Cell proliferation and cytotoxicity assays: 
 
 
2.3.1 MTT assay 
 
Cells were seeded at 1× 10
4
 cells / well of 96- well micro titer 
plates and cultured overnight and treated with fisetin in the 
dose range of 10 µM to 400 µM concentration and were 
allowed to proliferate 24/48 h (temperature 37
0
C, 5% CO2 and 
95% humidity). After proliferation, MTT performed following 
the previously described protocol (Mosmann, 1983). Plates 
was read at 570nm using a microplate reader and the 
concentration of fisetin that inhibited cell growth by 50% 
(IC50) was calculated. 
 
2.3.2 XTT assay 
 
XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-
Tetrazolium-5-Carboxanilide) assay was performed  using a 
commercially available kit (HiMedia, Cat. No. CCK015) 
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following the manufacturer’s recommendations. Cells after 
treatment were allowed to proliferate (temperature 37
0
C, 5% 
CO2 and 95% humidity). Activated XTT solution was added to 
the wells and cells were incubated for 2 to 4 hours and the 
absorbance was read at 450 nm using ELISA reader.  
 
2.3.3 Bromodeoxyuridine (BrdU) assay 
 
Cell proliferation was measured by performing BrdU (5-
bromo-2’-deoxyuridine) incorporation assay using 
commercially available kit (Calbiochem/Merck, Cat. No. 
QIA58, Whitehouse Station, NJ, USA) following the 
manufacturer’s guidelines. The absorbance was recorded at 
450 nm and measured intensity is proportional to the amount 
of incorporated BrdU in the cells. 
 
2.3.4 Crystal violet assay 
 
Crystal violet assay was performed to determine the effect of 
fisetin on cell viability following the protocol previously 
described (Lena et al.,2009). The treated and untreated control 
cells were stained with crystal violet (0.05% w/v) for 30 min 
after that wells were thoroughly washed with distilled water 
and destained with sorenson’s buffer. The absorbance of the 
extracted stain was measured at 540 nm. 
 
2.4 Assays to determine change in cell morphology and 
apoptotic cell death 
 
2.4.1 Crystal violet staining 
 
Light microscopy analysis of treated and untreated control 
cells was carried out by fixing the cells in 10% formalin saline 
and subsequent staining with 0.05 w/v crystal violet for 30 
minutes. Cells were observed under phase contrast microscope 
and images were captured (4×10X magnification). 
 
2.4.2 Hematoxylin and Eosin staining 
 
Cells after treatment were fixed in 10% formalin and the 
morphology change in both were analysed by staining the cells 
with hematoxylin and eosin following the protocol previously 
described (Fischer et al., 2008). Cells were observed under 
light microscope and images were captured (4×10 X 
magnification).  
 
2.5 Soft agar assay for colony formation 
 
A cell suspension (5×10
3
 cells/well) in 1ml of 0.3% agar with 
complete media was over laid on 35mm dish containing 0.5% 
base agar as described previously (Hamburger et al., 1978). 
The media was changed two times a week and cells were 
maintained under standard growth conditions (temperature 
37
0
C, 5% CO2 and 95% humidity) in a CO2 incubator (Forma 
Scientific, USA). After 15 days, the colonies formed in the 
untreated control and the treated groups were fixed with 3.7% 
paraformaldehyde and stained with crystal violet (0.05%) for 1 
hour. The colonies were counted under light microscope and 
images were captured (magnification 10 X). 
 
2.6 LDH cytotoxicity assay 
 
The release of lactate dehydrogenase from treated and 
untreated control cells was performed by using LDH –
cytotoxicity colorimetric Assay kit 11(catalog no.K313-500) as 
per the manufacturer’s recommendations. After the treatment 
of cells, the clear medium (10 μl/ well) from treated, control 





















Figure 1(a). Effect of fisetin on proliferation of A549 cells (MTT assay) –pilot studies. Treatment of A549 cells with 50 μM -250 μM 
concentration showed statistically significant (p<0.001) decrease in the proliferation of A549 cells. Data represents mean ± SD of six 
replicates. Intergroup comparisons were made between the cell control and the treated groups. Student’s t-test; ***P<0.001,**P< 0.01, 
verses control. 






























Figure 1(b)  Effect of fisetin on proliferation of NCI-H460 cells (MTT assay) –pilot studies. Treatment of NCI-H460 cells with 75μM -
275 μM concentration showed statistically significant (p<0.001) decrease in the proliferation of A549 cells. Data represents mean ± SD 
of six replicates. Intergroup comparisons were made between the cell control and the treated groups. Student’s t-test; ***P< 0.001 verses 
control. 
 
LDH reaction mixture (100 μl) was added to each well, and 
after that plates were incubated for 30 minutes at room temp. 
The reaction was stopped by adding 10 μl stop solution to each 
well. The red color intensity representing the LDH activity was 
measured at the absorbance of 450nm using a microplate 
reader. 
 
2.7 Statistical analysis 
 
Experiments have been carried out in triplicate on at least three 
different time intervals and the mean of replicate values were 
taken. All the experimental values were expressed as mean ± 
SD. Statistical analysis of the data was determined by 
Student’s t-test and comparisons were made between the 




3.1 Determination of IC50 of fisetin on A549 cell line 
 
The Preliminary pilot studies were carried out with various 
concentrations of fisetin ranging from 10 to 400 µM 
concentrations. Treatment of  A549 cells with 50 µM to 250 
µM concentration for 48 h showed a statistically significant 
((P<0.001) decrease in proliferation of cells however the 
concentration above 250 to 400 and below 50 µM  showed no 
appreciable decrease in proliferation of cells when compared to 
250 µM concentration (data not shown). Based on MTT assay 
the concentration of fisetin that inhibited cell growth by 50% 
(IC50) was determined as 190 µM concentration (Figure 1a). 
 
3.2 Determination of IC50 of fisetin on NCI-H460 cell line 
 
Preliminary pilot studies were carried out with various 
concentrations of fisetin ranging from 10 to 300 μM 
concentrations. Treatment of NCI-H460 with 10 to 50 μM 
concentration for 24 h showed no influence on the proliferation 
of cells as compared to control (data not shown). Whereas 
concentrations between 75 to 275μM showed statistically 
significant (P<0.001) decrease in the proliferation of NCI-
H460 cells. Based on MTT assay the concentration of fisetin 
that inhibited cell growth by 50% (IC50) was determined as 210 
µM concentration (Figure 1b). 
 
3.3 Effect of fisetin on growth and proliferation of NCI-H460 
and A549 cell line 
 
Based on preliminary pilot studies, the 1C50 doses were further 
confirmed by performing XTT, BrdU, crystal violet assays 
(Figure 2, 3, 4).These assays were performed to confirm results 
obtained from MTT assay and these assays were in agreement. 
Based on these cell viability and proliferation  assays it was 
observed that treatment with the specified concentrations of 
fisetin resulted in statistically significant decrease in cell 
viability, growth, survival and proliferation of A549 and NCI-
H460 cells .The IC50 doses were confirmed and used for 
carrying out further assays. 
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Figure 2 Effect of fisetin on proliferation of A549 and NCI-H46 cells (XTT assay) .Treatment of NCI-460 cells with fisetin resulted in a 
significant decrease in cell proliferation as compared with the control. Data represent mean ± SD of six replicates. Intergroup 



















Figure 3 Effect of fisetin on proliferation of A549 and NCI-H460 cells (BrdU assay). Treatment of A549 and NCI-H460 cells with fisetin 
resulted in a significant decrease in cell proliferation as compared with the control. Data represent mean ± SD of six replicates. 
Intergroup comparisons were made between cell control and treated group. Student’s t-test; ***P< 0.001 verses control. 
 
3.4 Effect of Fisetin on cell morphology-cytopathological and 
cytochemical analysis 
 
3.4.1 Crystal violet staining 
 
The fisetin treated A549 and NCI-H460 cells showed the 
presence of apoptotic bodies, cytoplasmic vacuolization, cell 
shrinkage, formation of stretched nuclei and nuclear 
fragmentation after staining the cells with crystal violet (0.05% 
w/v) for 30 min (Figure 5 A), however these typical features of 
cell death were not observed in untreated control A549 cells 
and NCI-H460. 
3.4.2 Hematoxylin and eosin Staining 
 
A549 treated cells showed decrease in cell number. The cells 
were smaller in size and some cells show cell shrinkage and 
loss of nuclei (cell death) after staining the cells with 
hematoxylin and eosin whereas they were not evident in the 
untreated control. NCI-H460 treated cells showed decrease in 
cell population with many cells showing loss of nuclei, and 
karyorrhexis was seen which, is a typical feature of apoptosis 
(Figure 5 B). 
 




























Figure  4 Effect of fisetin on proliferation of A549 and NCI-H460 cells (Crystal violet assay) –pilot studies. Treatment of A549 and NCI-
H460 cells with fisetin resulted in a significant decrease in cell proliferation as compared with control. Data represent mean ± SD of six 
replicates. Intergroupcomparisons were made between cell control and treated groups. Student’s t-test; ***P< 0.001 verses control. 
 
3.4.3 Effect of fisetin on cloning efficiency and surviving 
fraction 
 
Results revealed that A549 control cells showed a cloning 
efficiency of 0.82 as compared to cloning efficiency of 0.28 
observed in treated cells and NCI-H460 control cells showed a 
cloning efficiency of 1.18 as compared to cloning efficiency of 
0.34 observed in treated cells. Thus, it illustrates the significant 
decrease in the number of colonies and decrease in percentage 
of survival in fistein treated groups compared to that of 
untreated control (Table 1). As shown in figure fisetin 
treatment almost completely blocked the migration of A549 
and NCI-H460 cells, and antimetastatic effect was more 
evident in NCI-H460 treated cells (Fig. 5 C). 
 
3.4.4 Effect of fisetin on release of LDH 
 
Results indicate that the cells treated with fisetin showed 
marked increase in LDH release in both A549 and NCI-H460 
cells which was found to be statistically significant ( p<0.001) 




Currently over 50% of anticancer drugs available in the market 
for therapy werederived directly or indirectly from natural 
source (Younes et al., 2007). Dietary factors play an important 
role in prevention of cancer, hence large number of dietary 
compounds were tested to determine their chemopreventive / 
antiproliferative ability in invivo / invitro model systems. A549 
cells were derived from human alveolar carcinoma cell (Giard 
et al., 1973) and matched closely with type II alveolar cell 
phenotype. They share many characteristic features with 
human primary alveolar epithelial cell (Lieber et al., 1976). 
Hence they are widely used as models of  lung cancer (Wang 
et al., 2009; Shin et al., 2009)and as human primary alveolar 
epithelial cells in vitro (Tian et al., 2009; Mazzarella et al., 
2007). NCI-H460 cells are epithelioid cells isolated from 
pleural fluid of a patient with large cell carcinoma of lung. 
Inhibition of cell proliferation is a characteristic feature of 
majority of anticancer agents.  
 
Table 1 Effect of fisetin on colony efficiency and survival fraction – colony formation in soft agar 
 
Group No. of Colonies Colony Efficiency Surviving Fraction % Survival 
Control NCI – H460 52 1.04 - 100 
Treated NCI – H460 11 0.22 0.211 21 
Control A549 44 0.88 - 100 
Treated A549 13 0.26 0.295 30 
Table 1 indicates the cloning efficiency and surviving fraction of the fisetin treated A549 and NCI-H460 cells and untreated control cells. 
A549 and NCI-H460 control cells showed a cloning efficiency of 0.82 and 1.18 compared to treated A549 and NCI-H460 cells showing 
cloning efficiency 0.28 and 0.34 respectively. Decrease in percentage of survival was observed in both A549 and NCI-H460 treated cells 
compared to untreated control cells. 
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Figure 5 (A) Crystal violet staining revealed the presence of apoptotic bodies, cytoplasmic vacuolization, cell shrinkage, nuclear 
fragmentation and formation of stretched nuclei in fisetin treated A549 and NCI-H460 cells. Magnification: × 4 × 10. (B) Hematoxylin –
eosin staining revealed that fisetin treated A549 cells were smaller in size and some cells showed cell shrinkage and loss of nuclei (cell 
death)  and NCI-H460 cells showed showing loss of nuclei and karyorrhexis was seen which is a typical feature of apoptosis. However, 
no such features were evident in A549 and NCI-H460 control cells. Magnification:  × 4 × 10. (C) Figure illustrates the effect of fisetin on 
colony efficiency and surviving fraction of A549 and NCI-H460 cells. Colonies formed in soft agar after 15 days were stained with 
0.05% crystal violet and counted and images were captured. Magnification ×10. 
 
The flavonoid fisetin was reported to inhibit cell proliferation 
against several in vivo/in vitro models of carcinogenesis. The 
current study also showed significant inhibition of cell growth 
and proliferation was observed after treatment of pulmonary 
carcinoma cells with fisetin. In human, the Quadraplex (G4) 
forming sequences in telomeric DNA and C-myc promoter 
regions of DNA are associated with tumorigenesis. Ligands 
that can help to facilitate or stabilize formation of 
G4quadraplex structures and increase stabilization of 
G4quadraplex can prevent tumor cell proliferation and regarded 
as promising candidates as anti-cancer agents (Sen gupta et al., 
2013). In the recent years, particular efforts are under way to 
discover, design and synthesise new ligands that could help to 
regulate the stability of G-quadraplex structures. Fisetin is 
reported to act as a ligand for G4 DNA (Sengupta et al., 2013), 
and hence could have a tight control on the cell proliferation in 
A549 and NCI-H460 cells. This could be the reason for the 
observed inhibitory effects of fisetin on cell growth, viability 
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Figure 6 Effect of fisetin on LDH activity of A549 and NCI-H460 cells. Treatment of A549 and NCI-H460 cells with fisetin showed a 
significant increase in leakage of LDH into culture supernatant as compared to untreated control. Data represent mean ± SD of six 
replicates. Intergroup comparisons were made between cell control and treated group. Student’s t-test; ***P < 0.001 verses control. 
 
 
Neoplastic transformation takes place via a series of genetic 
and epigenetic changes that yield cell population with potential 
of proliferating independently of both external and internal 
signals. It is one of the hall marks of malignant transformation 
and most accurate in vitro indication of tumorigenicity (Shin et 
al., 1975). The decreased number of colonies and inhibition of 
anchorage independent growth of pulmonary carcinoma cells 
by fisetin strongly supported its potent antiproliferative effects. 
 
Hematoxylin and eosin staining is a valuable indicator of 
morphological and tissue architectural changes occurring 
during pathological conditions. This is an indispensible test to 
confirm malignant transformation of normal cells or to test 
efficacy of compounds to prevent pathological changes in 
cells/tissues. Results of hematoxylin and eosin staining were in 
line and support observations of cell growth assays, clonogenic 
assay. This confirmed growth inhibitory effects of fisetin on 
A549 and NCI-H40 cells. LDH is a cytosolic enzyme that 
leaks into culture supernatant or serum during membrane 
damage and injury. Increased leakage of LDH into culture 
supernatant of cells treated with fisetin implies alteration in 
membrane permeability and integrity thereby results in 




The results of the current study indicate growth inhibitory, 
antiproliferative and cytotoxic effects of fisetin on human 
pulmonary carcinoma cells A-549 and NCI-H460. Although 
the mechanism of action remains unclear at this stage of the 
study, it is presumed to be due to proapoptotic effects of fisetin 
and its subsequent implications on multiple cell signaling 
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